Congying Xie

Wenzhou Medical University - Second Affiliated Hospital

China

SCHOLARLY PAPERS

6

DOWNLOADS

218

TOTAL CITATIONS

2

Scholarly Papers (6)

1.

Specific Immune Phenotypes Protect Individuals Against COVID-19 Susceptibility and Severity: A Mendelian Randomization Study

Number of pages: 11 Posted: 19 Aug 2021
Wenzhou Medical University - Second Affiliated Hospital, Wenzhou Medical University - School of Laboratory Medicine and Life Science, Zhejiang University - Women’s Hospital, Wenzhou Medical University - Second Affiliated Hospital, Wenzhou Medical University - School of Laboratory Medicine and Life Science, Wenzhou Medical University - Division of Gastrointestinal Surgery, Wenzhou Medical University - School of Laboratory Medicine and Life Science, Wenzhou Medical University - Department of Urology, Wenzhou Medical University - Division of Gastrointestinal Surgery, Wenzhou Medical University - School of Laboratory Medicine and Life Science, Fudan University - Department of Pulmonary and Critical Care Medicine and Wenzhou Medical University - Division of Gastrointestinal Surgery
Downloads 71 (659,073)
Citation 1

Abstract:

Loading...

COVID-19, immune cell traits, Mendelian randomization, BAFF-R

2.

Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study

Number of pages: 55 Posted: 18 Aug 2020
Shanghai Jiao Tong University (SJTU) - Shanghai Lung Cancer Center, Jilin University (JLU) - Cancer Center, Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Geneplus-Beijing Co. Ltd., Shantou University - Cancer Hospital, Wenzhou Medical University - Second Affiliated Hospital, Nanchang University - Department of Radiation Oncology, Shanxi Bethune Hospital - Department of Cancer Biotherapy, Shanxi Tumor Hospital - Department of Respiratory - Ward One, Shanghai Jiao Tong University (SJTU) - Department of Oncology, Zhejiang Shuren University - Department of Thoracic Oncology, Ningbo Second Hospital - Radiotherapy and Chemotherapy Department 2, Government of the People's Republic of China - Department of Medical Oncology, Guangxi Medical University - Department of Medical Oncology of Respirotary, Geneplus-Beijing Co. Ltd., Geneplus-Beijing Co. Ltd., Geneplus-Beijing Co. Ltd. and Shanghai Jiao Tong University (SJTU) - Shanghai Lung Cancer Center
Downloads 67 (678,878)

Abstract:

Loading...

clonal architecture, EGFR, NSCLC, ctDNA

3.

Noninvasive Prediction of Lymph Node Status for Patients with Early-Stage Cervical Cancer Based on Radiomics Features from Ultrasound Images

Number of pages: 25 Posted: 05 Oct 2019
Wenzhou Medical University - Department of Radiation and Medical Oncology, Wenzhou Medical University - Department of Radiation and Medical Oncology, Wenzhou Medical University - Department of Radiation and Medical Oncology, Wenzhou Medical University, Wenzhou Medical University, Wenzhou Medical University, Wenzhou Medical University and Wenzhou Medical University - Second Affiliated Hospital
Downloads 33 (911,413)

Abstract:

Loading...

Early-stage cervical cancer, Ultrasound image, Lymph node metastasis, Radiomics

4.

Central Nervous System Efficacy of Rezivertinib (BPI-7711) in Advanced NCLC Patients with EGFR T790m Mutation: A Pooled Analysis of Two Clinical Trials

Number of pages: 33 Posted: 20 Mar 2023
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Shanxi Medical University - First Hospital, Shanxi Medical University - Department of Medical Oncology, Zhengzhou University - Department of Respiratory Medicine, Harbin Medical University - Department of Medical Oncology, Army Medical University - Institute of Cancer, Zhengzhou University - Department of Oncology, Sichuan University - Department of Respiratory and Critical Care Medicine, Linyi Cancer Hospital - Department of Medical Oncology, Zhengzhou University - Henan Provincial People's Hospital, Sichuan Cancer Hospital - Department of Medical Oncology, Chinese Academy of Sciences (CAS) - Key Laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Peking University - Department of Thoracic Medical Oncology, Qingdao University - Yantai Yuhuangding Hospital, Zhejiang University - The First Affiliated Hospital, Central South University - Thoracic Medicine Department II, Bengbu Medical College - First Affiliated Hospital, Sichuan University - Department of Thoracic Oncology, University of Science and Technology of China (USTC) - Department of Thoracic Cancer Chemotherapy, Guangdong Medical University - Department of Oncology, Shandong First Medical University - Department of Oncology, Chongqing University Cancer Hospital - Department of Palliative Care, Chongqing University Cancer Hospital, Soochow University - Department of Pulmonary and Critical Care Medicine, Xingtai Medical College - Cancer Center, Nanjing Medical University - Department of Oncology, People's Hospital of Deyang City - Department of Oncology, Xinjiang Medical University - Department of Pulmonary Medicine, Liuzhou People's Hospital - Department of Oncology, Dalian University - Department of Oncology, Central South University - Department of Respiratory Medicine, Henan University of Science and Technology - Department of Medical Oncology, Nanjing Medical University - Department of Respiratory Medicine, Government of the People's Republic of China - Department of Oncology, Xinjiang Medical University - Pulmonary Cancer Medicine, Huazhong University of Science and Technology - Tongji Medical College, Henan University - Department of Oncology, China Medical University - Liaoning Cancer Hospital & Institute, Huazhong University of Science and Technology - Department of Medical Oncology, Chinese Academy of Sciences (CAS) - Department of Thoracic Surgery, Xuzhou Medical University - Department of Radiotherapy, Handan Central Hospital - Department of Oncology, Wenzhou Medical University - Second Affiliated Hospital, Tianjin Medical University - Department of Medical Oncology, Anhui Medical University - Department of Respiratory and Critical Care Medicine, Bengbu Medical College - Department of Medical Oncology, Zhengzhou University - Department of Medical Oncology, Chongqing Medical University - Department of Respiratory and Critical Care Medicine, Hubei University of Arts and Science - Department of Oncology, Zhejiang University - Department of Respiratory and Critical Care Medicine, Shantou University - Department of Medical Oncology, Anhui Medical University - Department of Oncology, Soochow University - Second Affiliated Hospital, Tongji University - Department of Respiratory and Critical Care Medicine, Beta Pharma, Inc., Beta Pharma (Shanghai) Co., Ltd. and Beta Pharma (Shanghai) Co., Ltd.
Downloads 20 (1,046,436)

Abstract:

Loading...

Rezivertinib, BPI-7711, EGFR T790M mutation, CNS, NSCLC

5.

Concurrent Chemoradiotherapy with Extended Nodal Irradiation and/or Erlotinib in Locally Advanced Esophageal Squamous Cell Cancer: Long-Term Follow-Up of a Randomized Phase 3 Trial

Number of pages: 64 Posted: 07 Jun 2019
Wenzhou Medical University - Second Affiliated Hospital, Hangzhou Cancer Hospital - Department of Radiation Oncology, The First People’s Hospital of Huaihua, Wenzhou Medical University - Taizhou Hospital of Zhejiang Province, Chinese Academy of Sciences (CAS) - Department of Radiation Oncology, Bengbu Medical College - First Affiliated Hospital, Hangzhou Cancer Hospital, Anhui Provincial Hospital, Wuhan University - Department of Radiation and Medical Oncology, Kaohsiung Medical University - Kaohsiung Medical University Hospital, Central Hospital of Lishui City, Chinese Academy of Sciences (CAS) - Department of Radiation Oncology, Jiangsu Cancer Hospital, North Sichuan Medical College - First Affiliated Hospital, Hangzhou Cancer Hospital - Department of Radiation Oncology, Hangzhou Cancer Hospital - Department of Radiation Oncology, Hangzhou Cancer Hospital - Information Center, Sun Yat-sen University (SYSU), Chinese Academy of Medical Sciences - National Cancer Center and Hangzhou Cancer Hospital - Hangzhou Cancer Institute
Downloads 14 (1,118,726)
Citation 1

Abstract:

Loading...

esophageal squamous cell cancer, elective nodal irradiation, erlotinib

6.

Efficacy and Safety of Rezivertinib (BPI-7711) in Patients with Locally Advanced or Metastatic/Recurrent EGFR T790M Mutated NSCLC: A Phase IIb Study

Number of pages: 254 Posted: 11 May 2022
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Shanxi Medical University - Department of Medical Oncology, Sichuan University - Department of Respiratory and Critical Care Medicine, Zhengzhou University - Henan Provincial People's Hospital, Sichuan Cancer Hospital - Department of Medical Oncology, Chinese Academy of Sciences (CAS) - Key Laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Central South University - Thoracic Medicine Department II, Sichuan University - Department of Thoracic Oncology, Zhengzhou University - Department of Oncology, University of Science and Technology of China (USTC) - Department of Thoracic Cancer Chemotherapy, Guangdong Medical University - Department of Oncology, Army Medical University - Institute of Cancer, Harbin Medical University - Department of Respiratory Medicine, Linyi Cancer Hospital - Department of Medical Oncology, Shandong First Medical University - Department of Oncology, Peking University - Department of Thoracic Medical Oncology, Xingtai Medical College - Cancer Center, People's Hospital of Deyang City - Department of Oncology, Xinjiang Medical University - Pulmonary Cancer Medicine, Liuzhou People's Hospital - Department of Oncology, Dalian University - Department of Oncology, Central South University - Department of Respiratory Medicine, Zhengzhou University - Department of Respiratory Medicine, Henan University of Science and Technology - Department of Medical Oncology, Nanjing Medical University - Department of Respiratory Medicine, Government of the People's Republic of China - Department of Oncology, Xinjiang Medical University - Pulmonary Cancer Medicine, Henan University - Department of Oncology, China Medical University - Liaoning Cancer Hospital & Institute, Huazhong University of Science and Technology - Department of Medical Oncology, Chinese Academy of Sciences (CAS) - Department of Thoracic Surgery, Handan Central Hospital - Department of Oncology, Wenzhou Medical University - Second Affiliated Hospital, Tianjin Medical University - Department of Medical Oncology, Anhui Medical University - Department of Respiratory and Critical Care Medicine, Chongqing University Cancer Hospital - Department of Palliative Care, Xuzhou Medical University - Department of Radiotherapy, Bengbu Medical College - Department of Medical Oncology, Zhengzhou University - Department of Medical Oncology, Chongqing Medical University - Department of Respiratory and Critical Care Medicine, Hubei University of Arts and Science - Department of Oncology, Zhejiang University - Department of Respiratory and Critical Care Medicine, Shantou University - Department of Medical Oncology, Nanjing Medical University - Department of Oncology, Anhui Medical University - Department of Oncology, Tongji University - Department of Respiratory and Critical Care Medicine, Beta Pharma, Inc., Beta Pharma (Shanghai) Co., Ltd. and Beta Pharma (Shanghai) Co., Ltd.
Downloads 13 (1,131,047)

Abstract:

Loading...

Rezivertinib, BPI-7711, NSCLC, EGFR T790M mutation, Third-generation EGFR TKI